Why Gritstone Oncology's Stock is Trading Higher Today


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Gritstone Oncology's Stock Price And Volume Action

Gritstone Oncology (NASDAQ:GRTS) is currently up 6.87% to a price of $21.46. The stock's volume is currently 2.72 million, which is roughly 83.78% of its recent 30-day volume average of 3.24 million.

Why It's Moving

Benzinga Pro's real-time breaking news service shows some insight into what is affecting shares: Gritstone Oncology shares were trading higher after the company announced an agreement with Genevant to obtain a nonexclusive license to Genevant's LNP technology to develop and commercialize self-amplifying RNA vaccines against COVID-19.

Insights On Recent Price Action

The moving average price of the stock over the past 50 days was $3.98 at the time this article was published. In the past fifty-two weeks, the stock price has been as high as $22.47 and as low as $2.54.

Benzinga Pro provides investors with timely and accurate explanations of why a stock is moving. Subscribe to receive real-time alerts explaining stock price movements. Click here to learn more.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: MoversTrading IdeasBZI-WIIM